PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Ovintiv Inc. (OVV)
40.910.33 (-0.80%)
40.40 - 41.05
29.80 - 47.18
2.12M / 3.66M (Avg.)
18.02 | 2.27
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
144.54%
Net income growth at 50-75% of CRK's 208.50%. Martin Whitman would worry about lagging competitiveness unless expansions are planned.
6.81%
Some D&A expansion while CRK is negative at -67.39%. John Neff would see competitor’s short-term profit advantage unless expansions here deliver big returns.
132.49%
Some yoy growth while CRK is negative at -100.65%. John Neff would see competitor possibly managing deferrals more aggressively for short-term advantage.
No Data
No Data available this quarter, please select a different quarter.
-583.57%
Negative yoy working capital usage while CRK is 705.35%. Joel Greenblatt would see more free cash if revenue remains unaffected, giving a short-term advantage.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-101.49%
Negative yoy while CRK is 99.40%. Joel Greenblatt would see a near-term net income or CFO stability advantage unless competitor invests or writes down more aggressively.
-155.54%
Negative yoy CFO while CRK is 113.56%. Joel Greenblatt would see a disadvantage in operational cash generation vs. competitor.
-25.36%
Negative yoy CapEx while CRK is 1.10%. Joel Greenblatt would see a near-term FCF boost unless competitor invests for long-term advantage.
-1.35%
Negative yoy acquisition while CRK stands at 0.00%. Joel Greenblatt sees potential short-term cash advantage unless competitor’s deals yield big synergy.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-137.59%
Both yoy lines negative, with CRK at -100.00%. Martin Whitman suspects a cyclical or strategic rationale for cutting extra invests in the niche.
-148.60%
Both yoy lines negative, with CRK at -0.15%. Martin Whitman suspects a broader cyclical shift away from heavy investing across the niche.
4.34%
Debt repayment well below CRK's 100.00%. Michael Burry suspects heavier leverage risk or insufficient cash generation to keep pace.
300.00%
Stock issuance far above CRK's 54.66%. Michael Burry flags a significant dilution risk vs. competitor’s approach unless ROI is very high.
No Data
No Data available this quarter, please select a different quarter.